Background: People with unknown atrial fibrillation (AF), who are often asymptomatic, have a substantially increased risk of stroke. Although recommended in European guidelines, AF screening is not routinely performed. Screening at the time of influenza vaccination presents an ideal opportunity to detect AF in large numbers in a primary care medical setting, with an existing annual recall system for patients aged !65 years. Design: Cross-sectional pilot study of handheld smartphone electrocardiogram (iECG) screening to identify unknown AF. Methods: General practices in Sydney, Australia, were recruited during the influenza-vaccination period of April-June 2015. Practice nurses screened patients aged !65 years with a 30-second iECG, which has a validated algorithm for detecting AF in real time. In order to confirm the accuracy of the algorithm, two research cardiologists reviewed de-identified iECGs. In order to explore barriers and enablers, semi-structured interviews were conducted with selected nurses, practice managers and general practitioners. Results: Five general practices were recruited, and 973/2476 (39%) patients attending influenza vaccination were screened. Screening took an average of 5 minutes (range 1.5-10 minutes); however, abnormal iECGs required additional time. Newly identified AF was found in 8/973 patients (0.8%). The sensitivity of the iECG automated algorithm was 95% (95% confidence interval: 83-99%) and the specificity was 99% (95% confidence interval: 98-100%). Screening by practice nurses was well accepted by practice staff. Key enablers were the confidence and competence of nurses and a 'designated champion' to lead screening at the practice. Barriers were practice specific, and mainly related to staff time and funding. Conclusions: Screening with iECG during influenza vaccination by primary care nurses is feasible and well accepted by practice staff. Addressing barriers is likely to increase uptake.
Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting 5% of people aged !65 years, and its prevalence is predicted to at least double in the next 20 years due to the ageing population. 1 People with AF have greatly increased stroke risk, with such strokes likely to be severe. 2 At least one in three strokes are AF related, 2 and the proportion of strokes due to AF is increasing. The direct annual AF health system costs in Australia are at least $874 million, largely being stroke related. 3 Many people, particularly the elderly, are unaware that they have AF as they have no symptoms, with first diagnosis often made when they have a stroke. 2, 4 Stroke is highly preventable in AF with the appropriate use of oral anticoagulants (OACs), 4 but worldwide, OACs are under-prescribed, with rates of approximately 60% of those eligible. 5 In addition, only a quarter of people with AF-related stroke are on OACs at the time of their stroke. 2 International guidelines recommend opportunistic screening for AF in the clinic by pulse palpation in people aged !65 years in order to reduce stroke due to AF, 6 because increasing age is a strong risk factor for incident AF, as well as AF-related stroke. However, in practice, this recommendation is rarely implemented. Practice nurses are ideally placed to screen for AF, as people aged !65 years account for approximately a third of all general practice encounters. 7 Practice nurses have been used to deliver a range of interventions and to improve the management of chronic conditions in primary care in Australia. 8 In the UK, practice nurses have successfully delivered systematic AF screening using 12-lead electrocardiography (ECG); however, this was not deemed to be cost effective compared to general practitioner (GP) opportunistic screening. 9 Our group has demonstrated that opportunistic screening in pharmacies using a handheld smartphone ECG (iECG) is feasible and cost effective, 10 and that it is also feasible for practice nurses to screen using the iECG. 11 Ideally, iECG screening could be tied to a regular annual health appointment with the practice nurse, such as the seasonal influenza (flu) vaccination. A study in The Netherlands found that screening patients aged >65 years for AF during flu vaccination in the general practice setting was promising. 12 In Australia, the annual flu-vaccination programme is well entrenched and has excellent uptake, and is a time when patients are likely to be available and receptive to AF screening in an appropriate setting. Approximately 74% of Australians aged !65 years receive a flu vaccination each year, 13 mostly from the practice nurse. Our health economic model, developed and published with SEARCH-AF, 10 indicates that if a single time point screening for unknown AF was extended to the 74% of Australians aged between 65 and 84 years who have an annual flu shot, >1300 strokes would be prevented due to the first round of screening alone. Therefore, our study aimed to determine the feasibility of practice nurse screening in Australia during the flu-vaccination period.
Methods

Study design
A cross-sectional pilot study of smartphone-based screening in order to identify unknown AF in Sydney, Australia, was conducted between April 2015 and June 2015 (ACTRN12615000622505). The study was approved by the University of Sydney Human Ethics Committee (2014/962). The iECG screening device used was the AliveCor Heart Monitor (Figure 1 ), which has approval from the Australian Therapeutic Goods Administration as a Medical Device, Class IIa, and has an automated algorithm that we have previously validated. 14 A convenience sample of five general practices was recruited, and practice nurses at each general practice received face-to-face training from a member of the research team (LL) on implementing the screening protocol. This training involved an initial session of approximately 45 minutes and subsequent training/ device support as required. All people aged !65 years attending their general practice for the flu vaccination were eligible to participate, with the exception of those with insufficient cognitive capacity or English proficiency to understand the consent process. Eligible participants from participating general practices were notified of screening in a letter that accompanied the invitation to have the annual flu vaccination. The Participant Information Sheet was also enclosed. Participants provided verbal consent, and this was documented on a consent log. 
Screening procedure
Screening was conducted on consecutive participants attending the practice during the flu-vaccination period. Patients were asked to hold a smartphone in order to record an iECG for 30 seconds (Figure 1 ). The nurse entered the patient's details into the app and the iECG was then sent via Wi-Fi to a secure server and imported into the patient's electronic medical record. The algorithm provided an on-screen message at the end of the recording, which stated the recording was 'Normal', 'AF detected' or 'ECG unable to be classified'. For normal ECGs, no further action was taken. If AF was detected or if the ECG was not able to be classified, a 12-lead ECG was obtained, except where the participant had previously documented ECG abnormalities in their medical record. Subsequent management was at the discretion of the GP, and the study team had no involvement in determination of the management plan.
Individual patient-level data were not available to the study team. In order to confirm the accuracy of the automated algorithm, two research cardiologists (SBF and WL) reviewed de-identified iECGs. In order to ensure confidentiality, the research team could only view the iECGs on a purposebuilt study website that removed all patient identifiers from the obtained iECGs. After completion of the screening period, practices were asked to provide additional de-identified data only on those who had AF detected on the iECG. These data included demographic data, together with the patients' CHA 2 DS 2 -VASc score and information on whether the patients were prescribed OACs or antiplatelets before and after screening.
Process evaluation and qualitative analysis
In order to understand the relevant barriers and enablers to screening for AF in general practice, a detailed process evaluation was carried out. Semistructured interviews were conducted face-to-face with selected practice nurses, practice managers and GPs. Interviewees provided written informed consent. Interviews were audio-recorded, transcribed and analysed thematically by four members of the research team (LN, NL, LL and JO). The analysis explored participants' views on screening by nurses during the flu-vaccination period, the screening workflow and protocols for an abnormal result. The interviews were complete when thematic saturation was achieved. The research team discussed and refined the analysis in order to reach a final consensus on the main themes in terms of barriers and enablers. 
Results
General practices
Five general practices in urban Sydney were recruited to the study. One practice had participated in a previous trial of AF screening with the practice receptionist delivering the intervention. 11 The others had responded to an article about the study published in a Primary Health Network (previously Medicare Local) e-newsletter, or were recruited through personal contacts. Each practice had at least two practice nurses employed.
Participants
A total of 2476 patients aged !65 years attended the general practices for the annual flu vaccination. Of these, 972 (39%) unique patients had an iECG recorded. From these recordings, the on-device algorithm identified 846 iECGs as normal, 44 as possible AF and a further 82 were unable to be classified ( Figure 2 ). Across the different practices, screening was reported to take from 1.5 to 10 minutes.
AF identified from screening
Of the 44 participants with possible AF on iECG, 29 had a known history of AF. Of the 15 participants without a history of AF, 13/15 participants were referred for a 12-lead ECG. In total, newly identified AF was found in 8/972 patients (0.8%). The sensitivity of the iECG automated algorithm for detecting AF was 95% (95% confidence interval (CI): 83-99%) and the specificity was 99% (95% CI: 98-100%). As shown in Table 1 , of the eight patients with newly identified AF, one could not be re-identified within the practice and, similarly, of the 30 patients with known AF, one could not be re-identified within the practice. The mean age of the remaining seven patients with new AF was 80 AE 3 years, and three were male. Before screening, none were on OACs, and after screening, three were on OACs. In relation to antiplatelet medications, three were on antiplatelets before screening and two were commenced on antiplatelets after screening. All seven had a CHA 2 DS 2 -VASc score of !2.
Qualitative results
In total, 17 semi-structured interviews were conducted across all five practices, comprising seven nurses, five GPs and five practice managers. Interviews ranged from 5 to 14 minutes and the key barriers and enablers for each group are summarised in Figure 3 .
GPs. Overall, GPs really liked the device and the fact that it raised awareness of AF. They were positive about screening during flu vaccinations as it captured patients who only came into the practice very occasionally throughout the year, although they noted that it made this period very busy. They also liked nurses performing the screening. Barriers were very specific to each practice; for example, one practice was also participating in another study at the same time and had IT issues with setting up the Wi-Fi. The key message was that practices needed to recognise that the study would take time to set up, and so to appropriately plan for this. In this respect, it was key to have someone (either a GP or practice manager) at the practice to 'champion' the screening programme. Practice nurses. Practice nurses were very confident at providing screening. They noted that screening was very straightforward for the vast majority of patients who received a 'normal' reading. Nurses generally enjoyed the extra interaction with patients, who liked the screening.
GPs
The key barriers were how busy it made them during the flu-vaccination period, the need for elderly patients to hold the device very still to take a reading and the additional time required to follow up an abnormal result with the GP. Given that nurses often had many people waiting for flu vaccinations, an unexpected abnormal result put them under substantial time pressure, as additional time was not allocated for screening during the flu-vaccination consultation. Nurses from practices that had established protocols for dealing with abnormal results found this process much easier.
Practice managers. Practice managers were very important to the success of the screening program. A positive practice manager could 'champion' the program and greatly enhance its success. Engaging practice managers in the planning process for screening was helpful. One practice manager commented that their practice had taken the time to review their planning for the flu-vaccination process to include screening, and that this contributed to the success of the programme.
Practice managers highlighted the administrative, IT and filing requirements in addition to the nurses' time requirements in performing the screening. They suggested that funding would be desirable in order to cover the costs of the required IT setup and filing, which would provide an incentive for the time taken for screening.
Discussion
Screening for AF by practice nurses in the general practice setting is feasible and was generally well accepted by the practice staff. Key enablers were the confidence and competence of nurses providing screening and a 'designated champion' (any staff member) to lead screening at the practice. Barriers were mainly practice specific and included concurrent participation in another study, IT issues and failure to establish a protocol/workflow to deal with abnormal iECGs. Other barriers included no funding for the screening (i.e. no incentive to allocate additional practice time for the screening during the flu-vaccination consultation) and the additional time required to action abnormal iECGs (i.e. review and arrange 12-lead ECGs). Staff indicated that patients generally liked the device and the screening process. These enablers and barriers were generally similar to those identified recently by Taggar et al. in a UK survey of primary healthcare professionals seeking opinions on AF screening. 15 Consistent with findings from our previous pilot study, 11 the practice nurse model works well due to nurses' confidence in explaining and providing screening, ease of training and clinical understanding of the reasons for screening. Nurse-led screening during flu vaccination is clearly more feasible than opportunistic receptionist screening, as we were able to recruit more than 10-times as many patients in a similar time frame in this study compared to our previous pilot study. 11 Some practices liked the timing of the flu vaccination as a prompt for screening. GPs noted that this was a time of year when many patients in the target group attend the practice, and the flu vaccination provided a useful 'prompt' for screening. However, nurses and practice managers did note that it made the flu-vaccination period very busy, particularly when patients received a 'possible AF' or 'unclassified' reading that required follow-up. Screening could be done at a different time (e.g. during wound dressing or chronic care consultations), but does require some kind of prompt.
This study had several limitations. An important issue was that the version of the AliveCor algorithm used by the app during the study was subsequently discovered to have undergone an intentional change by AliveCor. 16 This algorithm provided 95% sensitivity and 99% specificity in this study, which is substantially better than has been reported by Desteghe et al., 17 but was less sensitive than the earlier version of the algorithm (98% sensitivity), although with greater specificity (99% vs. 91%). 10, 14 For this study, there was one case of new AF and one case of known AF, both of whom received a 'normal' algorithm interpretation, but were in AF at the time of the screening based on the research cardiologists' review. There is always a tradeoff between sensitivity and specificity, 18 and this compromise (95% sensitivity and 99% specificity) may be optimal. The major ECG issue in this study was the 'unclassified' iECGs that were clearly in sinus rhythm, but because of sinus tachycardia or bradycardia or broad QRS complexes could not be classified as normal. This category leads to a lot of unnecessary work in the primary care setting, and could easily be reduced by additional category(ies) of diagnosis in the AliveCor algorithm.
There were several limitations of the study in relation to recruitment. Only five metropolitan practices were recruited, which may not be representative of all practices in the state. There were marked variations in recruitment between the sites, ranging from 23 patients screened at one practice to 354 screened at another. Overall, the fact that only 39% of eligible patients were screened during the period was a limitation, and is likely to relate to the workload of nurses during flu vaccination and the lack of remuneration for screening. In addition, one site had been involved in a previous pilot study for AF screening, which may have influenced screening practice at that site in regard to the identification of unknown AF.
One interesting finding from this study is that evidence-based OAC prescription was not followed in four of the seven people with new AF, and antiplatelet prescription was increased contrary to guideline recommendations. This suggests that screening for AF alone is not enough, and that there may well be a place for a decision support tool to improve prescription practice. A number of programmes have been previously developed in order to increase evidence-based prescription of OACs, including electronic decision support tools, 19 targeted GP education programme, 20 and patient-focused education interventions. 21 The results of these programmes were generally positive, although they were also varied. 21 There is a need for future research to test an electronic decision support tool integrated with clinical software in order to improve evidence-based OAC prescription and 'close the gap' between evidence and practice in OAC prescription. Tying this with iECG screening for AF seems a logical use of e-medicine.
In summary, screening with iECG during flu vaccination by primary care nurses is feasible and well accepted by practice staff. Addressing barriers is likely to increase uptake.
